Novel patient-derived cell lines (PDCs) have been constructed under the Fukushima Translational Research Project. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of PDCs were……
| Inventor | Institute |
|---|---|
| Medical-Industrial Translational Research Center | Fukushima Medical University |
| SKU: | 160990 |
|---|---|
| Product description: | Novel patient-derived cell lines (PDCs) have been constructed under the Fukushima Translational Research Project. Our comparative histological and comprehensive gene expression analyses have shown that the characteristics of PDCs were… |
| Alternate name: | RSAR001, RSAR1 |
| Gender: | Male |
| Cellosaurus ID: | CVCL_E2TL |
| Cat. #: | 160990 |
|---|---|
| Unit size: | 1/7 volume of T-175 flask/vial |
| Cancer types: | Sarcoma |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Soft tissue |
| Gender: | Male |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Clear cell sarcoma;Soft tissue tumor |
| Primary citation: | Hakozaki et al. 2018. Anticancer res 38: 5035-5042. PMID: 30194147 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | RPMI1640 medium with 10% heat-inactivated FBS |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 |
| Storage medium: | CELLBANKER 2 |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
Hakozaki et al. 2018. Anticancer res 38: 5035-5042. PMID: 30194147 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.